Stefan Watzka
Overview
Explore the profile of Stefan Watzka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Illini O, Benej M, Lang-Stoberl A, Fabikan H, Brcic L, Sucher F, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685780
: Pleural mesothelioma (PM) is a rare type of cancer with poor prognosis. Prognostic and predictive biomarkers could improve treatment strategies in these patients. Programmed death ligand 1 (PD-L1), integrin-linked...
2.
Ay L, Steiner D, Fabikan H, Illini O, Krenbek D, Klikovits T, et al.
Lung Cancer
. 2024 Nov;
198:107997.
PMID: 39486111
Background: Phase 3 trials of neoadjuvant immunotherapy-based regimens have shown promising outcomes in patients with resectable non-small cell lung cancer (NSCLC). However, real-world data on treatment regimens with combined chemoimmunotherapy,...
3.
Illini O, Fabikan H, Fischer E, Lang-Stoberl A, Krenbek D, Jarius C, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407771
Adenosquamous carcinoma of the lung (ASC) is a rare non-small-cell lung cancer (NSCLC) subtype combining components of squamous cell carcinoma (SCC) and adenocarcinoma (AC). Data on ASC, particularly in Caucasian...
4.
Benej M, Klikovits T, Krajc T, Watzka S, Hochmair M, Krenbek D, et al.
Mediastinum
. 2023 Dec;
7:39.
PMID: 38090031
Background: Primary mediastinal liposarcoma is a rare malignancy of mesenchymal origin with local aggressive biological behavior which is often diagnosed as an incidental finding without any symptoms. Chemoresistance and low...
5.
Benej M, Klikovits T, Krajc T, Bohanes T, Schulte L, Hochmair M, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046743
Objectives: The ratio of positive and resected lymph nodes (LN ratio) has been shown to be prognostic in non-small cell lung cancer (NSCLC). Contrary to the LN ratio, calculating the...
6.
Hochmair M, Weinlinger C, Schwab S, Naber J, Setinek U, Krenbek D, et al.
Anticancer Drugs
. 2019 Jul;
30(7):e0787.
PMID: 31305295
The second-generation ALK tyrosine kinase inhibitor brigatinib has recently been approved in the European Union for use after crizotinib treatment in patients with EML4-ALK-rearranged lung cancer. In the current study,...
7.
Besler C, Urban D, Watzka S, Lang D, Rommel K, Kandolf R, et al.
Eur J Heart Fail
. 2016 Jun;
18(12):1442-1451.
PMID: 27292200
Aims: Inflammatory heart disease represents an important cause of chronic dilated cardiomyopathy (DCM). Predicting the clinical course of patients with inflammatory cardiomyopathy (iCMP) is difficult, and the prognostic value of...